SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice
6 references·6 citing·35 second hop
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice (2003)Pharmacological characterization of the e…Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)Human psychopharmacology of E…Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. (1996)Co-administration of MDMA wit…Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites (1988)Pharmacologic profile of MDMA…Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. (1988)Elevation of serum prolactin …Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Neurotoxicity of the psychede…In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain (1987)In vitro and in vivo neuroche…Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine (2018)Dark Classics in Chemical Neu…MDMA: Interactions with other psychoactive drugs (2011)MDMA: Interactions with other…Lost in translation: preclinical studies on 3,4‐methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans (2011)Lost in translation: preclini…Pharmacology of stimulants prohibited by the World Anti‐Doping Agency (WADA) (2008)Pharmacology of stimulants pr…Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones (2004)Effect of Repeated (‘Binge’) …Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat (2003)Acute and long-term consequen…Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (2005)Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals (1985)Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram (2000)3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003)The Background and Chemistry of MDMA (1986)The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers (2000)Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density (2003)Ecstasy: Are animal data consistent between species and can they translate to humans? (2006)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) (2006)A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users (2006)Behavioral effects of MDMA (‘ecstasy’) on adult zebrafish (2011)Serotonin and Hallucinogens (1999)The rush to adrenaline: drugs in sport acting on the β‐adrenergic system (2008)Doping in sport and exercise: anabolic, ergogenic, health and clinical issues (2015)Dietary Supplement and Food Contaminations and Their Implications for Doping Controls (2020)Hallucinogens (2004)Psychedelics (2016)Psychedelics Promote Structural and Functional Neural Plasticity (2018)Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research (2022)Therapeutic mechanisms of psychedelics and entactogens (2023)Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations (1995)A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy (1997)The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) (2003)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)
this work references cited by second hop

References

  • 1987Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.530 cited
  • 2001Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research344 cited
  • 1988Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites301 cited
  • 1987In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain297 cited
  • 1988Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.179 cited
  • 1996Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.147 cited

Cited by

  • 2008Pharmacology of stimulants prohibited by the World Anti‐Doping Agency (WADA)143 cited
  • 2018Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine106 cited
  • 2011MDMA: Interactions with other psychoactive drugs76 cited
  • 2003Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat75 cited
  • 2011Lost in translation: preclinical studies on 3,4‐methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans74 cited
  • 2004Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones67 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work